← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 1, 2014Last known activity
Oct 1, 2025
Acquired by LabCorp on Aug 23, 2017
Timeline
1990s
- Jun 1, 1999
ChromaDex— Founded
2010s
- Aug 23, 2017
LabCorp— Acquired By
Drugs by trial phase (1 distinct, 10 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT07251608Lead sponsorPhase 1Oct 1, 2025
- NCT06919328CollaboratorN/AOct 31, 2024
- NCT06005350CollaboratorN/ANov 1, 2023
- NCT05732051CollaboratorPhase 2Mar 16, 2023
- NCT04110028CollaboratorPhase 1/Phase 2Sep 30, 2019
- NCT03642990CollaboratorPhase 2Oct 1, 2018
- NCT03562468Lead sponsorN/AJun 13, 2018
- NCT02712593CollaboratorPhase 2Mar 1, 2016
- NCT02921659CollaboratorPhase 1/Phase 2Apr 1, 2015
- NCT02191462CollaboratorPhase 1Jul 1, 2014
Details
- Founded
- Irvine, CA, US Jun 1, 1999
- Last known activity
- Oct 1, 2025